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LETTERS TO THE EDITOREFFECT OF RADIAL ARTERY
OR SAPHENOUS VEIN
CONDUITAS A SECOND GRAFT
ON LATE CLINICAL OUTCOME
AFTER CORONARYARTERY
BYPASS GRAFTING SURGERY
To the Editor:
We read with great interest the arti-
cle by Zacharias and colleagues1 re-
garding late outcomes after radial
artery (RA) versus saphenous vein
(SV) grafting during reoperative coro-
nary artery bypass surgery. We do not
support their statement that RA versus
SV grafting at reoperation was associ-
ated with a late survival benefit analo-
gous to what had been previously
reported by the same group2 when
the RA was used as a second arterial
conduit in primary coronary artery
bypass grafting (CABG) surgery.
In that article2 data analysis was per-
formed on a retrospective observa-
tional CABG series. The cumulative
0- to 6-year survival was better for
patients with RA conduits versus
propensity-matched patients with SVs
as a second conduit (925 patients in
each group). It might be reasonable to
assume that angiographic graft patency
influenced survival. However, the an-
giographic RA conduit’s patency
(1.8  1.4 years to redo angiographic
analysis) was 68.2%, which is statisti-
cally not better (P ¼ .11) than the SV
graft patency rate (63.3%). The au-
thors pointed out that patency compar-
ison derived from the subcohort of
restudied patients who received bothThe Editor welcomes submissions for possible publica-
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The JournalRA and SV conduits, in which each pa-
tient served as his or her own control
subject, has shown significantly better
RA graft patency (SV graft angio-
graphic failure rate of 41% vs
23.9% observed for RA conduits,
P ¼ .039)).2 Although we are discus-
sing a second conduit of choice in
a CABG cohort with an internal tho-
racic artery to the left anterior descend-
ing coronary artery (LAD), each
patient can serve as his or her own con-
trol subject only if tested conduits (RA
or SV) were randomly assigned to graft
either the circumflex or the right coro-
nary territory. Furthermore, target ves-
sel stenoses, diameters, and territories
of runoff (area of distribution) should
be similar and determined in inclusion
criteria. Although the authors are pro-
ponents of arterial grafting, we as-
sumed that RA conduits were placed
to the next best target other than the
LAD. If RA conduits were all applied
to the largest non-LAD target, the
cross-sectional area of their runoff cir-
culation would have been larger than
that of the SV grafts performed, which
could therefore be expected to failmore
readily than the RA grafts. Further-
more, when the SV grafts are used
only to the second-best target, patency
is 90% at 5 years on optional angio-
grams and 80% at 9 years in the
protocol-directed angiograms (pro-
spective, randomized, single-center
trial).3 Achouh and associates4 have re-
cently reported a similar angiographic
patency rate at 10 years after CABG
surgery for both conduits (83% of
RA conduits vs 81% of SV grafts).
Hayward and coworkers5 concluded
that use of the RA or SV for the second
conduit during primary CABG did not
significantly influence clinical out-
come at 6 years. There was no signifi-
cant difference in absolute survival in
the RA group versus that seen in the
SV group (similar number of patients,
16 deaths in each group, 4 deaths
were cardiac in cause in the RA group
vs 2 deaths in SV group). Unfortu-
nately, the cause of death is unknown
in the patient population of Zachariasof Thoracic and Cardiovascular Surgeand colleagues,1 and thus the death
rate might be independent of cardiac
factors.
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My coauthors and I reviewed the
letter by Nezic and colleagues1 related
to our recent article in the Journal.2 Al-
though we appreciate their opinion, we
were surprised that the letter at issue1
did not discuss our article2 per se.
Rather, it used our recent article as
a springboard to jump back to a 2004
article from our group,3 making essen-
tially the same point as in several pre-
vious letters that have discussed other
articles comparing the effects on late
coronary bypass surgery (CABG) out-
comes of use of radial artery (RA) ver-
sus saphenous vein (SV) as a second
grafting conduit. We stand by our
statement that the survival benefit
observed with RA versus SV graftingry c Volume 140, Number 4 941
